ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.
企業コードCLPT
会社名Clearpoint Neuro Inc
上場日Jul 03, 2019
最高経営責任者「CEO」Mr. Joseph Michael Burnett
従業員数115
証券種類Ordinary Share
決算期末Jul 03
本社所在地120 S. Sierra Avenue
都市SOLANA BEACH
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号92075
電話番号19499006833
ウェブサイトhttps://www.clearpointneuro.com/
企業コードCLPT
上場日Jul 03, 2019
最高経営責任者「CEO」Mr. Joseph Michael Burnett
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし